Consultancy Services : Regulatory Strategy Support

IS YOUR CLINICAL DEVELOPMENT STRATEGY READY FOR SUCCESS?

Leverage IDDI Statistical Knowledge of the Regulatory Approval Process to Optimize your Clinical Development Strategy

Approval-optimization strategies and regulatory statistics play a pivotal role in ensuring the success of your clinical trials and eventual approval by regulatory authorities. This is where seeking expert guidance becomes invaluable. IDDI Consultants are experts in the methodological, statistical and regulatory aspects of clinical trials and have a longstanding interest in regulatory approval strategies.

PLEASE FILL IN THE FORM BELOW TO ACCESS OUR PODCAST ON APPROVAL-REGULATORY STRATEGIES

Regulatory Strategy

Discover in this podcast:

  • How IDDI provides the right expertise and guidance to a SOUND statistical design that will give your promising drug all possible chances of approval.
  • What is regulatory statistics.
  • The importance of approval-optimization strategies.
  • How do we help our Sponsors optimize their regulatory strategy.

Speakers:

  1. Elisabeth Coart, PhD: Director Statistical Consulting & Research, IDDI
  2. Everardo Saad, MD: Medical Director, IDDI

Do you need any support with your next clinical development strategy ?

  • By implementing regulatory-compliant statistical methodologies and innovative strategies, IDDI optimizes your clinical development path and reduces time to market.
  • Robust statistical knowledge of regulatory guidances and process ensures data quality and increases the chances of regulatory approval.
  • Helping you determine the right sample size, appropriate endpoints, and effective randomization techniques, ensures your product meets the regulatory requirements of evidence.

IDDI will help you with the strategic decisions that are required for further clinical drug development and approval of the product.

Contact us today!

PODCAST REGULATORY STATISTICS